Hemangio Journal

Lactate and cholesterol metabolism are linked in HSA, and a statin-dipyridamole combo slowed tumour growth in mice.

Published on: August 16, 2026

A new study using gene expression profiling has identified three molecular subtypes of canine splenic hemangiosarcoma, each with different therapeutic implications.

Published on: August 8, 2026

The lipid compound shrank hemangiosarcoma tumors in mice by remodeling the environment around the tumor.

Published on: July 17, 2026

Doxorubicin extended median survival to 82 days in dogs with acute hemorrhage from presumed hemangiosarcoma where surgery was not an option.

Published on: July 10, 2026

Adding blood-based liquid biopsy to wellness visits increased preclinical cancer detection from 12% to 55% in a 419-dog screening study.

Published on: July 6, 2026

A 2026 review explores the link between UV exposure and dermal hemangiosarcoma in dogs

Published on: June 28, 2026

A new review breaks down the tests available today and still in development, and what they can and cannot do for dogs with hemangiosarcoma.

Published on: June 20, 2026

OXC-101 shows early antitumor activity in post-operative hemangiosarcoma.

Published on: May 22, 2026

Canine hemangiosarcoma cells take up boron through LAT1, making them vulnerable to neutron irradiation.

Published on: May 17, 2026

Organoids and xenografts reveal PLAAT3 as a key driver of invasion

Published on: April 4, 2026

Liver involvement remains the strongest negative prognostic indicator, but pulmonary and muscular metastases showed no significant impact on survival.

Published on: February 25, 2026

Hemangiosarcoma cells use lactate to activate genes that let them synthesize asparagine from glutamine.

Published on: February 16, 2026